Literature DB >> 11737324

Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease.

P A Fox1, S E Barton, N Francis, M Youle, D C Henderson, D Pillay, M A Johnson, L Fearfield, B G Gazzard, C B Bunker.   

Abstract

OBJECTIVE: To report a novel clinical presentation: a chronic erosive herpes simplex virus (HSV) infection of the penis which developed in AIDS patients following the commencement of highly active antiretroviral therapy (HAART). The lesions were unresponsive to antiviral treatments which had previously been effective, and this could not be accounted for in terms of increased antiviral resistance.
DESIGN: Detailed case-note review and investigation of three cases which presented at two large HIV units in London.
METHODS: Review of all histology with immunohistochemistry for HSV, HSV drug susceptibility assays, tissue typing and measurement of in vitro lymphocyte functional activity against HSV.
RESULTS: The histology of the lesions was the same in each case, with the presence of HSV on immunohistochemistry and an unusual prominence of plasma cell and eosinophils in the inflammatory infiltrate. HSV-specific lymphoproliferative responses were normal in two cases, but subnormal in a third case. All individuals shared the HLA class I molecules B72 and Cw0202 and the class II allele DRB4.
CONCLUSION: We believe this to be a previously unreported adverse consequence of HAART, the result of partial immune restoration, reminiscent of the the recently described syndrome of immune recovery vitritis.

Entities:  

Mesh:

Year:  1999        PMID: 11737324     DOI: 10.1046/j.1468-1293.1999.00003.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  16 in total

Review 1.  Improving the care of patients with genital herpes.

Authors:  S Drake; S Taylor; D Brown; D Pillay
Journal:  BMJ       Date:  2000-09-09

Review 2.  Immune restoration diseases reflect diverse immunopathological mechanisms.

Authors:  Patricia Price; David M Murdoch; Upasna Agarwal; Sharon R Lewin; Julian H Elliott; Martyn A French
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

Review 3.  Immune restoration inflammatory syndromes: apparently paradoxical clinical events after the initiation of HAART.

Authors:  Matthias Stoll; Reinhold E Schmidt
Journal:  Curr HIV/AIDS Rep       Date:  2004-09       Impact factor: 5.071

4.  Illness of Immune Reconstitution: Recognition and Management.

Authors:  Edward M Gardner; Elizabeth Connick
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

5.  Increase in HSV shedding at initiation of antiretroviral therapy and decrease in shedding over time on antiretroviral therapy in HIV and HSV-2 infected persons.

Authors:  Emily S Ford; Amalia S Magaret; Cedric W Spak; Stacy Selke; Steve Kuntz; Lawrence Corey; Anna Wald
Journal:  AIDS       Date:  2018-11-13       Impact factor: 4.177

Review 6.  [Immune restoration inflammatory syndromes].

Authors:  M Stoll; H Heiken; G M N Behrens; R E Schmidt
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743

7.  Immune Restoration Inflammatory Syndromes: The Dark Side of Successful Antiretroviral Treatment.

Authors:  Matthias Stoll; Reinhold E. Schmidt
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

8.  Increased risk of genital ulcer disease in women during the first month after initiating antiretroviral therapy.

Authors:  Susan M Graham; Linnet Masese; Ruth Gitau; Dickson Mwakangalu; Walter Jaoko; Jeckoniah Ndinya-Achola; Kishor Mandaliya; Norbert Peshu; Jared M Baeten; R Scott McClelland
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12       Impact factor: 3.731

9.  Update on immune reconstitution inflammatory syndrome: progress and unanswered questions.

Authors:  Colleen F Kelley; Wendy S Armstrong
Journal:  Curr Infect Dis Rep       Date:  2009-11       Impact factor: 3.725

10.  Transient Increase in Herpes Simplex Virus Type 2 (HSV-2)-Associated Genital Ulcers Following Initiation of Antiretroviral Therapy in HIV/HSV-2-Coinfected Individuals.

Authors:  Kenneth H Fife; Kenneth Mugwanya; Katherine K Thomas; Jared M Baeten; Connie Celum; Elizabeth Bukusi; Guy de Bruyn; Andrew Mujugira; Bellington Vwalika; Anna Wald; Jairam R Lingappa
Journal:  J Infect Dis       Date:  2015-12-23       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.